BACH1 and HIF1 alpha predict response to neoadjuvant nab-paclitaxel (nP) treatment in early breast cancer (BC) - Vladimirova, V.; Schneeweiss, A.; Jackisch, C.; Weber, K. E.; Denkert, C.; Schmatloch, S.; Karn, T.; Fasching, Peter; Braun, S.; Szeto, C.; Sinn, B.; Van Mackelenbergh, M.; et al. (ANNALS OF ONCOLOGY, 2021)
CRIS-Team WoS Importer:2021-05-28